文献速递炎症性肠病

系统综述与Meta分析:粪菌移植用于活动性溃疡性结肠炎诱导缓解

Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2017-06-14

该系统综述与Meta分析检索Medline、Embase和Cochrane图书馆至2017年2月,纳入14项队列研究和4项随机对照试验(RCT),评估粪菌移植(FMT)诱导活动性溃疡性结肠炎(UC)缓解的疗效与安全性。RCT的Meta分析显示,供体FMT组临床缓解率28%(39/140)高于安慰剂组9%(13/137),OR 3.67(95%CI 1.82-7.39,P<.01);临床应答率49%(69/140)高于安慰剂组28%(38/137),OR 2.48(95%CI 1.18-5.21,P=.02)。结论认为尽管流程存在差异,FMT对UC诱导缓解似乎有效,短期未见重大安全性信号,仍需进一步研究确定剂量频率和制备方法,并探索其作为维持治疗的可行性、疗效和安全性。

要点

  • RCT的Meta分析中,供体FMT组临床缓解28%(39/140) vs 安慰剂组9%(13/137),OR 3.67(95%CI 1.82-7.39,P<.01)。
  • 供体FMT组临床应答49%(69/140) vs 安慰剂组28%(38/137),OR 2.48(95%CI 1.18-5.21,P=.02)。
  • 队列研究中临床缓解24%(39/168;95%CI 11%-40%)。

核心结论

  • 尽管流程存在差异,FMT对活动性UC诱导缓解似乎有效,短期未见重大安全性信号;仍需进一步研究以明确剂量频率和制备方法,并探索其作为维持治疗的可行性、疗效和安全性。

研究设计与样本

  • 系统综述纳入所有研究设计的原始研究,Meta分析仅纳入随机对照试验(RCT);共纳入14项队列研究和4项RCT,各研究方案差异显著。
  • 检索Medline(Ovid)、Embase和Cochrane图书馆,检索时间从建库至2017年2月。

主要发现

  • RCT的Meta分析中,供体FMT组临床缓解39/140(28%) vs 安慰剂组13/137(9%),OR 3.67(95%CI 1.82-7.39,P<.01)。
  • RCT的Meta分析中,供体FMT组临床应答69/140(49%) vs 安慰剂组38/137(28%),OR 2.48(95%CI 1.18-5.21,P=.02)。
  • 队列研究中临床缓解39/168(24%;95%CI 11%-40%)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 各研究在盲法、FMT给药流程、治疗强度和供体粪便处理方法上存在差异,且各研究方案差异显著。
  • 需进一步研究以更好地确定剂量频率和制备方法,并探索其作为维持治疗的可行性、疗效和安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative colitis (UC). Interpretation of efficacy of FMT for UC is complicated by differences among studies in blinding, FMT administration procedures, intensity of therapy and donor stool processing methods. AIM: To determine whether FMT is effective and safe for the induction of remission in active UC. METHODS: Medline (Ovid), Embase and the Cochrane Library were searched from inception through February 2017. Original studies reporting remission rates following FMT for active UC were included. All study designs were included in the systematic review and a meta-analysis performed including only randomised controlled trials (RCTs). RESULTS: There were 14 cohort studies and four RCTs that used markedly different protocols. In the meta-analysis of RCTs, clinical remission was achieved in 39 of 140 (28%) patients in the donor FMT groups compared with 13 of 137 (9%) patients in the placebo groups; odds ratio 3.67 (95% CI: 1.82-7.39, P<.01). Clinical response was achieved in 69 of 140 (49%) donor FMT patients compared to 38 of 137 (28%) placebo patients; odds ratio 2.48 (95% CI: 1.18-5.21, P=.02). In cohort studies, 39 of 168 (24%; 95% CI: 11%-40%) achieved clinical remission. CONCLUSIONS: Despite variation in processes, FMT appears to be effective for induction of remission in UC, with no major short-term safety signals. Further studies are needed to better define dose frequency and preparation methods, and to explore its feasibility, efficacy and safety as a maintenance agent.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Costello SP, Soo W, Bryant RV, et al. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther. 2017. PMID: 28612983. doi:10.1111/apt.14173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。